menu search

ATGL / U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO

U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO
Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Index was up 23.5% year-to-date, while the S&P 500 was up 14.0%. Renaissance Capital's IPO ETF tracks Renaissance IPO Index, and top ETF holdings include Palantir Technologies and Kenvue. Read More
Posted: Nov 4 2023, 00:21
Author Name: Seeking Alpha
Views: 022896

ATGL News  

U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO

By Seeking Alpha
November 4, 2023

U.S. IPO Weekly Recap: Biotech Lexeo Stumbles After $100 Million IPO

Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Inde more_horizontal


Search within

Pages Search Results: